Citation Impact
Citing Papers
Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
2018
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004
B cell depletion in autoimmune disease.
2003
Chronic immune thrombocytopenic purpura in children: Assessment of rituximab treatment
2005
CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction
2005
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Treatment of Vascular Rejection With Rituximab in Cardiac Transplantation
2005
Siglecs and their roles in the immune system
2007 Standout
Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia
2007
Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)
2002
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis
2004
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias
2007
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Rituximab as Treatment for Refractory Kidney Transplant Rejection
2004
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults
2004
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
The role of B cells in rheumatoid arthritis
2003
Paradoxical roles of the immune system during cancer development
2006 Standout
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura
2005
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Chemical Lectinology: Tools for Probing the Ligands and Dynamics of Mammalian Lectins In Vivo
2015 StandoutNobel
Nine patients with anti‐neutrophil cytoplasmic antibody‐positive vasculitis successfully treated with rituximab
2005
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Immune thrombocytopenic purpura in adults
2007
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Rituximab for Refractory Wegener's Granulomatosis
2005
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura
2007
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
2014
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal
2009
A review of the current use of rituximab in autoimmune diseases
2008
Management of adult idiopathic thrombocytopenic purpura.
2006
Works of Patty Bunch being referenced
Pharmacokinetics and Imaging of 212 Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients
2013
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
2000